Atlas Trials

5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder

Clinical trial NCT05452772 · RECRUITING

Trial details

NCT number
NCT05452772
Sponsor
Johns Hopkins University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Tobacco Use Disorder
Start date
2023-11-01
Primary completion
2026-12-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.